Pfaff, E., Remke, M., Sturm, D., Benner, A., Witt, H., Milde, T., . . . Pfister, S. (2010). TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. Journal of clinical oncology, 28(35), . https://doi.org/10.1200/JCO.2010.31.1670
Chicago-Zitierstil (17. Ausg.)Pfaff, Elke, et al. "TP53 Mutation Is Frequently Associated with CTNNB1 Mutation or MYCN Amplification and Is Compatible with Long-term Survival in Medulloblastoma." Journal of Clinical Oncology 28, no. 35 (2010). https://doi.org/10.1200/JCO.2010.31.1670.
MLA-Zitierstil (9. Ausg.)Pfaff, Elke, et al. "TP53 Mutation Is Frequently Associated with CTNNB1 Mutation or MYCN Amplification and Is Compatible with Long-term Survival in Medulloblastoma." Journal of Clinical Oncology, vol. 28, no. 35, 2010, https://doi.org/10.1200/JCO.2010.31.1670.